Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis.

Sofia VM, Da Sacco L, Surace C, Tomaiuolo AC, Genovese S, Grotta S, Gnazzo M, Petrocchi S, Ciocca L, Alghisi F, Montemitro E, Martemucci L, Elce A, Lucidi V, Castaldo G, Angioni A.

Mol Med. 2016 May 26;22. doi: 10.2119/molmed.2016.00010. [Epub ahead of print]

2.

Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis.

Rygiel AM, Beer S, Simon P, Wertheim-Tysarowska K, Oracz G, Kucharzik T, Tysarowski A, Niepokój K, Kierkus J, Jurek M, Gawliński P, Poznański J, Bal J, Lerch MM, Sahin-Tóth M, Weiss FU.

Hum Mutat. 2015 Mar;36(3):350-6. doi: 10.1002/humu.22747.

3.

Pancreatic cancer risk in hereditary pancreatitis.

Weiss FU.

Front Physiol. 2014 Feb 20;5:70. doi: 10.3389/fphys.2014.00070. eCollection 2014. Review.

4.

Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.

Joergensen MT, Geisz A, Brusgaard K, Schaffalitzky de Muckadell OB, Hegyi P, Gerdes AM, Sahin-Tóth M.

Pancreas. 2011 May;40(4):540-6. doi: 10.1097/MPA.0b013e3182152fdf.

5.

Pancreas divisum.

DiMagno MJ, Wamsteker EJ.

Curr Gastroenterol Rep. 2011 Apr;13(2):150-6. doi: 10.1007/s11894-010-0170-8. Review.

6.

The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.

Gasiorowska A, Talar-Wojnarowska R, Czupryniak L, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E.

Dig Dis Sci. 2011 Mar;56(3):894-901. doi: 10.1007/s10620-010-1349-4. Epub 2010 Jul 30.

7.

Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.

Wartmann T, Mayerle J, Kähne T, Sahin-Tóth M, Ruthenbürger M, Matthias R, Kruse A, Reinheckel T, Peters C, Weiss FU, Sendler M, Lippert H, Schulz HU, Aghdassi A, Dummer A, Teller S, Halangk W, Lerch MM.

Gastroenterology. 2010 Feb;138(2):726-37. doi: 10.1053/j.gastro.2009.10.048. Epub 2009 Nov 10.

8.

Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.

Kereszturi E, Szmola R, Kukor Z, Simon P, Weiss FU, Lerch MM, Sahin-Tóth M.

Hum Mutat. 2009 Apr;30(4):575-82. doi: 10.1002/humu.20853.

9.

Role of genetic disorders in acute recurrent pancreatitis.

Keim V.

World J Gastroenterol. 2008 Feb 21;14(7):1011-5. Review.

10.

Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI; Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas.

Gut. 2007 Oct;56(10):1460-9. No abstract available.

11.

Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Teich N, Rosendahl J, Tóth M, Mössner J, Sahin-Tóth M.

Hum Mutat. 2006 Aug;27(8):721-30. Review.

12.

Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.

Weiss FU, Simon P, Bogdanova N, Mayerle J, Dworniczak B, Horst J, Lerch MM.

Gut. 2005 Oct;54(10):1456-60. Epub 2005 Jun 29.

Supplemental Content

Support Center